| Axial spondyloarthritis J Sieper, D Poddubnyy The Lancet 390 (10089), 73-84, 2017 | 1139 | 2017 |
| EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ... Annals of the rheumatic diseases 79 (6), 700-712, 2020 | 900 | 2020 |
| Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis D Poddubnyy, H Haibel, J Listing, E Märker‐Hermann, H Zeidler, J Braun, ... Arthritis & Rheumatism 64 (5), 1388-1398, 2012 | 566 | 2012 |
| Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group RGW Lambert, PAC Bakker, D van der Heijde, U Weber, M Rudwaleit, ... Annals of the rheumatic diseases 75 (11), 1958-1963, 2016 | 511 | 2016 |
| Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis D Poddubnyy, M Rudwaleit, H Haibel, J Listing, E Märker-Hermann, ... Annals of the rheumatic diseases 70 (8), 1369-1374, 2011 | 487 | 2011 |
| Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception … D Poddubnyy, M Rudwaleit, H Haibel, J Listing, E Märker-Hermann, ... Annals of the rheumatic diseases 71 (10), 1616-1622, 2012 | 443 | 2012 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 352 | 2018 |
| ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update S Ramiro, E Nikiphorou, A Sepriano, A Ortolan, C Webers, X Baraliakos, ... Annals of the rheumatic diseases 82 (1), 19-34, 2023 | 324 | 2023 |
| Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS) D Poddubnyy, KGA Hermann, J Callhoff, J Listing, J Sieper Annals of the rheumatic diseases 73 (5), 817-823, 2014 | 309 | 2014 |
| High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis GR Heiland, H Appel, D Poddubnyy, J Zwerina, A Hueber, H Haibel, ... Annals of the rheumatic diseases 71 (4), 572-574, 2012 | 264 | 2012 |
| Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised … J Sieper, J Listing, D Poddubnyy, IH Song, KG Hermann, J Callhoff, ... Annals of the rheumatic diseases 75 (8), 1438-1443, 2016 | 248 | 2016 |
| MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group WP Maksymowych, RGW Lambert, M Østergaard, SJ Pedersen, ... Annals of the rheumatic diseases 78 (11), 1550-1558, 2019 | 236 | 2019 |
| Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs IH Song, DA Poddubnyy, M Rudwaleit, J Sieper Arthritis & rheumatism 58 (4), 929-938, 2008 | 235 | 2008 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 230 | 2019 |
| Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ... The Lancet 395 (10217), 53-64, 2020 | 213 | 2020 |
| Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study T Diekhoff, KGA Hermann, J Greese, C Schwenke, D Poddubnyy, ... Annals of the rheumatic diseases 76 (9), 1502-1508, 2017 | 180 | 2017 |
| Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care D Poddubnyy, J Vahldiek, I Spiller, B Buss, J Listing, M Rudwaleit, ... The Journal of rheumatology 38 (11), 2452-2460, 2011 | 167 | 2011 |
| Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis … IH Song, KG Hermann, H Haibel, CE Althoff, D Poddubnyy, J Listing, ... Annals of the rheumatic diseases 70 (7), 1257-1263, 2011 | 163 | 2011 |
| Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study J Braun, X Baraliakos, A Deodhar, D Poddubnyy, P Emery, EM Delicha, ... Rheumatology 58 (5), 859-868, 2019 | 154 | 2019 |
| High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial … D Poddubnyy, M Protopopov, H Haibel, J Braun, M Rudwaleit, J Sieper Annals of the rheumatic diseases 75 (12), 2114-2118, 2016 | 154 | 2016 |
Kay-Geert A. HermannSenior Lecturer, Radiology, Charité Universitätsmedizin BerlinVerified email at charite.de
